Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Reducing unnecessary and harmful care for kidney transplant patients
November 26, 2014
Kidney transplantation is life-changing and even life-saving for hundreds of Canadians every year, but in about 30% of patients, the drugs that prevent organ rejection also allow the normally harmless BK virus to replicate out of control, potentially causing serious complications including transplant failure. Dr. Greg Knoll led a team of investigators, which included Drs.
Dean Fergusson
,
Tim Ramsay
, Michaël Chassé and Louise Lebel, to see if a commonly used antibiotic called levofloxacin could prevent this infection.
The clinical trial, which was recently published in the
Journal of the American Medical Association (JAMA)
, showed that levofloxacin does not prevent BK virus replication and in fact, can cause harm in some patients. While the failure of this drug is disappointing, this rigorous evidence should ensure that kidney transplant patients are no longer exposed to this unnecessary and potentially harmful drug. This research was covered in a variety of medical publications, including
Infection Control Today
.
Funder(s):
Canadian Institutes of Health Research
Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with its faculties of Medicine and Health Sciences. The Ottawa Hospital Research Institute includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease. Research at Ottawa Hospital Research Institute is supported by The Ottawa Hospital Foundation.
For further information, please contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
Office: 613-737-8899 x73687
Cell: 613-323-5680
padmoore@ohri.ca